Envestnet Asset Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Envestnet Asset Management’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-13,927	Closed	-$250K	–	3045
2017 Q4	$250K	Sell	13,927 -460	-3%	-$5.66K	﹤0.01%	1743
2017 Q3	$170K	Buy	14,387 +1,410	+11%	+$15.8K	﹤0.01%	1892
2017 Q2	$136K	Buy	12,977 +423	+3%	+$4.31K	﹤0.01%	2021
2017 Q1	$138K	Buy	12,554 +4,043	+48%	+$46.9K	﹤0.01%	2063
2016 Q4	$115K	Buy	+8,511	New	+$119K	﹤0.01%	2132
2016 Q1	–	Sell	-4,235	Closed	-$73K	–	3210
2015 Q4	$73K	Sell	4,235 -126	-3%	-$2.26K	﹤0.01%	2509
2015 Q3	$87K	Buy	+4,361	New	+$100K	﹤0.01%	2406

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Envestnet Asset Management's SCMP Position: Q1 2018 in Review

Envestnet Asset Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 13,927 shares — an estimated $250K sold.

Envestnet Asset Management first reported a position in SCMP in Q3 2015 and held it in 7 quarters. The position peaked at $250K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

Envestnet Asset Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Envestnet Asset Management sold 13,927 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $250K.
Envestnet Asset Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q3 2015 and held it in 7 quarters.
Envestnet Asset Management's Sucampo Pharmaceuticals, Inc. position peaked at $250K in Q4 2017.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Envestnet Asset Management's 13F filing for Q1 2018, filed 9 May 2018.